Authors:
Dietlein, M
Weber, K
Gandjour, A
Moka, D
Theissen, P
Lauterbach, KW
Schicha, H
Citation: M. Dietlein et al., Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer: priority for a PET-based strategy after nodal-negative CT results, EUR J NUCL, 27(11), 2000, pp. 1598-1609
Authors:
Dietlein, M
Weber, K
Gandjour, A
Moka, D
Theissen, P
Lauterbach, KW
Schicha, H
Citation: M. Dietlein et al., Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules: a decision analysis based on cost reimbursement in Germany, EUR J NUCL, 27(10), 2000, pp. 1441-1456
Authors:
Krug, B
Dietlein, M
Groth, W
Stutzer, H
Psaras, T
Gossmann, A
Scheidhauer, K
Schicha, H
Lackner, K
Citation: B. Krug et al., Fluor-18-fluorodeoxyglucose positron emission tomography (FGD-PET) in malignant melanoma - Diagnostic comparison with conventional imaging methods, ACT RADIOL, 41(5), 2000, pp. 446-452
Authors:
Baer, FM
Theissen, P
Crnac, J
Schmidt, M
Deutsch, HJ
Sechtem, U
Schicha, H
Erdmann, E
Citation: Fm. Baer et al., Head to head comparison of dobutamine-transoesophageal echocardiography and dobutamine-magnetic resonance imaging for the prediction of left ventricular functional recovery in patients with chronic coronary artery disease, EUR HEART J, 21(12), 2000, pp. 981-991
Authors:
Jungehulsing, M
Scheidhauer, K
Damm, M
Pietrzyk, U
Eckel, H
Schicha, H
Stennert, E
Citation: M. Jungehulsing et al., 2(F-18)-fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation, OTO H N SUR, 123(3), 2000, pp. 294-301
Authors:
Dietlein, M
Moka, D
Scheidhauer, K
Schmidt, M
Theissen, R
Voth, E
Eschner, W
Schicha, H
Citation: M. Dietlein et al., Follow-up of differentiated thyroid cancer: comparison of multiple diagnostic tests, NUCL MED C, 21(11), 2000, pp. 991-1000
Authors:
Moka, D
Voth, E
Dietlein, M
Larena-Avellaneda, A
Schicha, H
Citation: D. Moka et al., Technetium 99m-MIBI-SPECT: A highly sensitive diagnostic tool for localization of parathyroid adenomas, SURGERY, 128(1), 2000, pp. 29-35
Authors:
Schmidt, M
Theissen, P
Crnac, J
Jochims, M
Voth, E
Baer, FM
Schicha, H
Erdmann, E
Citation: M. Schmidt et al., Clinical value of magnetic resonance imaging to visualize coronary artery stenoses: a comparison with coronary angiography and myocardial scintigraphy, DEUT MED WO, 124(44), 1999, pp. 1294-1300
Authors:
Schomacker, K
Gaidouk, MI
Rumyantseva, VD
Fischer, T
Lohr, H
Salditt, S
Liebenhoff, S
Schicha, H
Citation: K. Schomacker et al., Synthesis of tumour affine Yb-169-and Y-90-porphyrin complexes and animal experiments with different Yb-169-porphyrins, NUKLEARMED, 38(7), 1999, pp. 285-291
Authors:
Dietlein, M
Dressler, J
Eschner, W
Leisner, B
Reiners, C
Schicha, H
Citation: M. Dietlein et al., Guidelines for iodine-131 whole-body scintigraphy in differentiated thyroid cancer, NUKLEARMED, 38(6A), 1999, pp. 213-214
Citation: M. Dietlein et H. Schicha, External budget, internal budgeting and inhouse performance audits: Call for active cooperation of nuclear medicine clinics, NUKLEARMED, 38(6), 1999, pp. 3-6
Citation: A. Khandani et H. Schicha, Two-step radioiodine therapy during a single hospital visit in patients with benign thyroid disorders - Observations on 100 patients, NUKLEARMED, 38(5), 1999, pp. 140-143
Authors:
Dietlein, M
Moka, D
Dederichs, B
Hunsche, E
Lauterbach, KW
Schicha, H
Citation: M. Dietlein et al., Cost-effectiveness-analysis: Radioiodine or antithyroid drugs as first-line therapy of hyperthyroidism due to Graves' disease, NUKLEARMED, 38(1), 1999, pp. 7-14
Authors:
Dietlein, M
Dederichs, B
Weigand, A
Schicha, H
Citation: M. Dietlein et al., Radioiodine therapy and thyroid-associated orbitopathy: risk factors and preventive effects of glucocorticoids, EXP CL E D, 107, 1999, pp. S190-S194
Authors:
Schneider, CA
Voth, E
Moka, D
Baer, FH
Melin, J
Bol, A
Wagner, R
Schicha, H
Erdmann, E
Sechtem, U
Citation: Ca. Schneider et al., Improvement of myocardial blood flow to ischemic regions by angiotensin converting enzyme inhibition with quinaprilat IV - A study using [O-15] waterdobutamine stress positron emission tomography, J AM COL C, 34(4), 1999, pp. 1005-1011